Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary

About this update from North China Pharmaceutical Company Ltd. Class A

Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for North China Pharmaceutical Company Ltd. Class A